Trial NCT04022876

View at ClinicalTrials.gov 
Org. Study IDs: ALRN-6924-1-03

Last trial update was posted on 2022-10-10

MeSH Interventions

Carboplatin Pemetrexed Topotecan

MeSH Conditions

Lung Neoplasms Small Cell Lung Carcinoma

Other Conditions

Non Small Cell Lung Cancer Small-cell Lung Cancer

Stopping Reasons

With a favorable safety profile the difference between treatment groups for the primary composite endpoint was not sufficient to generate statistically significant results with the targeted sample size

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID